Alexion to Present at the Jefferies & Co. 2nd Annual Healthcare Conference
More News related to ALXN
- Alexion to Present at the Morgan Stanley Global Healthcare Unplugged Conference
- Alexion Secures U.S. Patent for ALXN6000, a First-In-Class Anti-CD200 Monoclonal Antibody
- David Moenning’s Daily State of the Markets: 07/29
- Pre-Open Movers 7/29: U.S. Steel (X) Up on Strong Results; Zoran (ZRAN) Lower on Results/Guidance
- Alexion Pharmaceuticals (ALXN) Tops Q2 Views; Guides Higher
More News related to Press Releases
- Top 10 News Items 9/2-9/5: Commodity Stocks Continue Slide; PIMCO's Gross Waits on the Sidelines; Unemployment Rate Jumps to 5-Yr High
- Trading Radar for 9/8: Finisar (FNSR), K12 (LRN) Report; Consumer Credit for July Due
- Unusual 11 Mid-Day Movers 9/5: SNDK, UST, SIRF, SPNC Higher; PEC, ABM, GBE, SWHC Lower
- Notable Analyst Rating Changes 9/5: UL, MON, NAV, HOS Upgraded; ANF, TJX, AMD, NBR Downgraded
- Notable Mergers and Acquisitions of the Day 9/5: MO/UST, SNDK, ABX
CHESHIRE, Conn., June 18 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Dr. Leonard Bell, Chief Executive Officer of Alexion Pharmaceuticals, will present at the Jefferies & Co. 2nd Annual Healthcare Conference in New York City at 4:15 p.m., ET on Wednesday, June 25, 2008.
An audio webcast of Dr. Bell's remarks will be available live. You can access the webcast at: www.alexionpharm.com. An archived version of the remarks will also be available through the Company's web site for a limited time following the conference.
[ALXN-G]
SOURCE Alexion Pharmaceuticals, Inc.
Related Categories
Press ReleasesStocks Mentioned
-1.96Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
